Altered molecular targets, such as E-cadherin (CDH1), MMP9, Survivin (BIRC5), Cytokeratin 5 (KRT5), VEGFA, IL15, TNF-α (TNF), TRAIL (TNFSF10), and Tenascin-C (TNC), exhibited increased expression in our study, which correlates with their upregulation in tumor samples from individuals with OC. This evidence concerns the gene BIRC5 and neoplasm.